4.6 Article

Domain Transfer Learning for MCI Conversion Prediction

期刊

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
卷 62, 期 7, 页码 1805-1817

出版社

IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
DOI: 10.1109/TBME.2015.2404809

关键词

Alzheimer's disease (AD); domain transfer learning; feature selection; mild cognitive impairment converters (MCI-C); sample selection

资金

  1. NIH [EB006733, EB008374, EB009634, MH100217, AG041721, AG042599]
  2. National Natural Science Foundation of China [61422204, 61473149, 61473190]
  3. Jiangsu Natural Science Foundation for Distinguished Young Scholar [BK20130034]
  4. Specialized Research Fund for the Doctoral Program of Higher Education [20123218110009]
  5. NUAA Fundamental Research Funds [NE2013105]
  6. Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ131108]
  7. Alzheimer's Disease Neuroimaging Initiative (ADNI)
  8. National Institutes of Health [U01 AG024904]
  9. National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
  10. Abbott
  11. AstraZeneca AB
  12. Bayer Schering Pharma AG
  13. Bristol-Myers Squibb
  14. Eisai Global Clinical Development
  15. Elan Corporation
  16. Genentech
  17. GE Healthcare
  18. GlaxoSmithKline
  19. Innogenetics
  20. Johnson and Johnson
  21. Eli Lilly and Co.
  22. Medpace, Inc.
  23. Merck and Co., Inc.
  24. Novartis AG
  25. Pfizer Inc
  26. F. Hoffman-La Roche
  27. Schering-Plough
  28. Synarc, Inc.
  29. Alzheimer's Association
  30. Alzheimer's Drug Discovery Foundation

向作者/读者索取更多资源

Machine learning methods have successfully been used to predict the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD), by classifying MCI converters (MCI-C) from MCI nonconverters (MCI-NC). However, most existing methods construct classifiers using data from one particular target domain (e.g., MCI), and ignore data in other related domains (e.g., AD and normal control (NC)) that may provide valuable information to improve MCI conversion prediction performance. To address is limitation, we develop a novel domain transfer learning method for MCI conversion prediction, which can use data from both the target domain (i.e., MCI) and auxiliary domains (i.e., AD and NC). Specifically, the proposed method consists of three key components: 1) a domain transfer feature selection component that selects the most informative feature-subset from both target domain and auxiliary domains from different imaging modalities; 2) a domain transfer sample selection component that selects the most informative sample-subset from the same target and auxiliary do-mains from different data modalities; and 3) a domain transfer support vector machine classification component that fuses the selected features and samples to separate MCI-C and MCI-NC patients. We evaluate our method on 202 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) that have MRI, FDG-PET, and CSF data. The experimental results show the proposed method can classify MCI-C patients from MCI-NC patients with an accuracy of 79.4%, with the aid of additional domain knowledge learned from AD and NC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据